Metabolites derived from superoxide (02"-) and nitric oxide (NO.) play an important role in antimicrobial and antitumoral defense, but may also harm the host. Low levels of such metabolites can also facilitate viral replication because of their mitogenic effects on cells. Most viruses grow better in proliferating cells, and indeed, many viruses induce in their host cell changes similar to those seen early after treatment with mitogenic lectins. Influenza and paramyxoviruses activate in phagocytes the generation of superoxide by a mechanism involving the interaction between the viral surface glycoproteins and the phagocyte's plasma membrane. Interestingly, viruses that activate this host defense mechanism are toxic when injected in the bloodstream of animals. Mice infected with influenza virus undergo oxidative stress. In addition, a wide array of cytokines are formed in the lung, contributing to the systemic effects of influenza. Oxidative stress is seen also in chronic viral infections, such as AIDS and viral hepatitis. Oxidant production in viral hepatitis may contribute to the emergence of hepatocellular carcinoma, a tumor seen in patients after years of chronic inflammation of the liver. Antioxidants and agents that downregulate proinflammatory cytokines and lipid mediators may be a useful complement to specific antiviral drugs in the therapy of viral diseases.
INTRODUCTION
The term "reactive oxygen species" (ROS) refers to an array of metabolites derived from molecular oxygen (02), superoxide anion radical (02"-) being the primary one-electron reduction product arising from 02. Superoxide may react with nitric oxide (NO.; formally termed "nitrogen 108 Peterhans monoxide"), an easily diffusible gas derived from arginine by enzymatic reaction (1) , or nonenzymatically by direct reduction from nitrite (2) , to give nitroperoxide (ONOO-). Depending on the relative proportions at which NO. and 02"-are produced, NO. can also act as an antioxidantlimiting lipid peroxidation (3) . ROS and nitric oxide with its unstable metabolites termed reactive nitrogen intermediates (RNI) are key elements in antimicrobial and antitumoral defense, but contribute also to aging and the pathogenesis of a wide array of infectious and noninfectious diseases (for a review, see 4) . Less well known, but no less important are the multiple roles of ROS and RNI in normal physiology. For example, a low level of ROS is required for mitogenic cell transformation (5) , and nitric oxide is a second messenger in brain and involved in the regulation of blood pressure (1) . The physiological roles of ROS and RNI are particularly important because viruses, as intracellular parasites, depend on the biosynthetic mechanisms of their host cells. The link between the role of ROS and cell activation began to be appreciated only recently (for a review, see 5) , much later than the virucidal effects of viruses (6) . First indications that cell activation played a role in viral replication began to emerge at about the same early time, however. Thus, viruses were shown to grow better in lymphocytes treated with mitogenic lectins (7, 8) and influenza viruses of the H2N2 subtype were found to activate lymphocytes mitogenically (9) . In a study on the biochemical effects of Semliki Forest virus on chicken embryo cells, we noted that the alterations induced in mitochondria by this Togavirus were similar to those induced by treatment with fetal calf serum, a well-known mitogenic stimulus (10) . Looking for evidence of activation in other cell types, we observed that influenza and paramyxoviruses stimulate a respiratory burst in phagocytic cells. Thus, unaware at that time of the metabolic role of ROS in cell activation, we found that these viruses can activate an effector function of host defense. Activation of ROS generation by influenza and paramyxoviruses in the absence of antiviral antibodies (11, 12) was of interest with respect to reports dating back to the 1940s, when these viruses had been shown to induce fever and even hemorrhages in internal organs (13, 14) . The conditions for the induction of ROS in vitro closely resembled those required for induction of toxic effects in vivo, with no requirement for viral replication in either case. In fact, the similarity extends even further because filamentous influenza virus particles, which are more toxic than spherical ones when injected in animals (15), are also more potent inducers of ROS generation in vitro (16). These observations led us to propose that ROS could play a role in the symptoms and pathology of influenza and other viral infections (17, 18) .
This concept of viral pathogenesis was put to the test using a mouse model of influenza. Animals infected intranasally develop severe systemic symptoms, including a decrease in body temperature and weight and anorexia, and succumb at days five and six postinfection. The infection remains restricted to the airways and lungs and is characterized by
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109 massive bronchitis and pneumonia leading to decreased pO2 and increased pCO2 in the blood (unpublished observation). Cells lavaged out of the lung are primed for enhanced ROS production, as shown by the increase in 02"-release in response to the tumor-promoting agent PMA. As an additional factor contributing to enhanced ROS production, the activity of xanthine oxidase, an enzyme generating 02"-, increased in lung homogenates. Analysis of major small molecular antioxidants (~-tocopherol, ascorbate, and glutathione) showed no change in the ratio of reduced to oxidized forms, but the concentrations of antioxidants decreased in the lung during infection, indicating that the antioxidantbuffering capacity diminishes during influenza in mice (19, 20) . In a more protracted model of influenza, Oda and coworkers showed that intravenously injected pyran copolymer-conjugated superoxide dismutase protects against the lethal effect of influenza (21). Since pyran copolymers are well-known antiviral agents (22, 23) , this observation is difficult to interpret. Interestingly, as first demonstrated by Bykova and coworkers (24), NO. also seems to play a role in the pathogenesis of influenza, and indeed, it was very recently demonstrated that agents interfering with the formation of NO. can have a beneficial effect in murine influenza (25).
The role of oxidants in influenza is complicated by several factors, among them the compartmental nature of infection. Even in the airways and lungs, not all regions are affected to the same extent, which poses problems with the conventional biochemical analysis of antioxidants because changes in the microenvironment may not be detected in tissue homogenates. In addition, as mentioned above, although influenza is a local infection of the airways and lung, disease symptoms can be severe both in mice and humans. In humans, influenza is characterized by headache, fever, and myalgia in addition to the respiratory symptoms related to the infection of the respiratory tract (26). Moreover, humans taking certain drugs that are detoxified in the liver may suffer from drug toxicity because of decreased liver function in the course of infection or after vaccination with influenza virus (27). A similar effect was observed also in murine influenza, with a decrease in the demethylation of 14C-aminopyrine (unpublished observation). The systemic effects of influenza may be caused by cytokines produced in the lung and released into the bloodstream. In mice infected with influenza virus, we demonstrated in the broncoalveolar lavage fluid a wide array of cytokines and lipid mediators, including tumor necrosis factor (TNF), interleukin-1 (IL-1), interferon-7, granulocyte macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), IL-6, and leukotriene B4 (28). It is noteworthy that, in particular, interferons can cause influenzalike symptoms in humans (29).
Although ROS are known to be virucidal (6, 30) , oxidants could actu- Oxidants also influence the pathogenesis of other viral diseases, in particular infection with HIV. Humans infected with HIV are under chronic oxidative stress, as shown by changes in the small molecular antioxidants ascorbic acid, (0~-tocopherol, carotenoids, selenium, superoxide dismutase, and in particular, glutathione) (for a review, see 35). Moreover, also pointing to oxidative stress are enhanced plasma levels of hydroperoxides, malondialdehyde, and clastogenic factors (36, 37) . In vitro, manipulations that result in enhanced oxidative stress enhance the replication of HIV (38, 39) , possibly via activation of NFKB, a transcription factor that stimulates the replication of HIV and transcription of a number of proinflammatory cytokine genes, among them TNF-R (40). The product of this gene is of particular interest, because its action on cells is linked to the promotion of intracellular oxidative stress, possibly as a result of enhanced ROS production in mitochondria (41) or by lipoxygenase (42) . HIV may stimulate ROS production by various mechanisms, including interaction of gp125 with the cell membrane (43) and via Tat, the transactivating protein (44) . Furthermore, mycoplasmas, which are known to stimulate HIV replication, may also act by increasing oxidative stress, either by producing H202 (45) or by stimulating the respiratory burst in phagocytic cells in a fashion similar to paramyxoviruses and influenza viruses (46) . Finally, coinfection with mycoplas- (47) . The altered redox status seems to contribute to HIV pathogenesis in several ways. As the most dramatic effect, it favors the inexorable and ultimately fatal decrease in the number of CD4 T-cells and many of the immune dysfunctions reported in HIV-infected individuals (for a review, see 35).
Much evidence suggests that death of the CD4 T-cells occurs by apoptosis, a process in which oxidants have been shown to play an important role, and that can be prevented or slowed down by antioxidants (35, 48) .
Several viruses can cause cancer by mechanisms involving oncogenes and tumor suppressor genes (reviewed in 49, 50) . In addition to these "classical" mechanisms, oxidant stress could also contribute to viral oncogenesis. In particular, several taxonomically diverse viruses cause hepatitis (51, 52) . Interestingly, only in hepatitis B virus is there convincing evidence for a role of classical mechanisms of viral cancerogenesis (53) . Infection with hepatitis viruses may last for years and is accompanied by inflammation, a condition associated with oxidative stress (54) .
Enhanced levels of ROS and RNI are known to be genotoxic (55) . Genotoxic effects may be accentuated by chronic tissue destruction leading to cell proliferation, because the latter results in enhanced fixation of mutations. A similar situation is encountered when potential carcinogens are tested at the maximum tolerated dose (55) .
Of particular interest is the formation of NO. in viral infections of the central nervous system, because NO. formed by inflammatory cells could interfere with the normal role of this gas as a second messenger in neurons (1) . Possibly, formation of NO,, could explain some mental alterations seen in many viral infections of the brain. For example, such alterations occur in rabies and in particular in Borna, a viral infection previously known in horses and sheep, and more recently suspected to be a cause of some mental disorders in humans (56) . In fact, the severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease were recently shown to correlate with the induction of nitric oxide synthase (57) , and the induction of this enzyme was also demonstrated in rabies, allergic encephalomyelitis (58) , and lymphocytic choriomeningitis (59) . RNI, along with ROS, could also be responsible for neuronal death (60) , exemplifying again that these metabolites may have both "metabolic" and toxic effects. Furthermore, in some instances, NO,, production may not be induced, but the cells may be primed for enhanced NO. synthesis in response to secondary stimuli, as was observed with lymphocytic choriomeningitis (61) and bovine viral diarrhea viruses (62) . This effect may be related to the immunosuppression observed during infection in vivo.
Finally, HIV infection (63) and HIV gp120 (64) were shown to enhance the production of NO. in human monocytes and exert neurotoxic effects via NO. in vitro, respectively. Moreover, NO . -mediated toxicity of HIV and Maedi Visna virus (a lentivirus of sheep) Tat was demonstrated in rats after intracerebral injection (65, 66) . Although these
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Peterhans examples would tend to suggest that NO, may play a negative role in a number of viral infections, NO, can also exert antiviral effects (67, 68) .
For example, NO. is thought to mediate antiviral effects of interferon-y against ectromelia, vaccinia, and herpes simplex viruses in mice, as inhibitors of iNOS-abrogated protection (69) . Inhibition of viral replication by NO, was also reported for Friend leukemia virus (70) and vesicular stomatitis virus (71) .
IS THERE A PLACE FOR ANTIOXIDANTS IN VIRAL DISEASES?
As discussed above, there is now much evidence that oxidants play a complex role in viral diseases, starting from influences on host cell metabolism and viral replication and extending to desired inactivating effects on viruses and less desired toxic effects on host tissue. Use of antioxidants in the therapy of viral diseases can therefore be expected to act at many different levels. Although for reasons outlined above it has remained difficult to demonstrate changes in the redox status of small molecular antioxidants, recent observations indicate that clear deficits in antioxidants can have quite dramatic effects on the outcome of viral infections. Most remarkable is the observation that mice made deficient in selenium and vitamin E may be killed by Coxsackie virus strains, which are harmless in selenium-sufficient animals. The unexpected observation that a number of animals inoculated with an attenuated strain produced a virulent strain capable of also killing animals sufficient in selenium and vitamin E suggests that the antioxidant status of a host may even influence viral evolution by as yet unknown mechanisms (72) (73) (74) . Antioxidants, particularly when given in a blend and at proportions present in a balanced diet of fruits and vegetables, are not toxic, and no untoward effects are to be expected from their use as a supportive adjunct to conventional therapy in viral diseases. Whether this is also true for synthetic antioxidants, like BHT, is less clear, as indicated by the observation that this antioxidant prevented the immune response of chickens to Newcastle disease virus. Interestingly, BHT also prevented the lethal effect of this virus in birds (75) .
A therapy should also target additional mechanisms that contribute to the symptoms and pathology of viral diseases, such as certain cytokines, NO,, and lipid mediators. Of course, one could argue that this approach fails to interfere directly with the replication of the virus, and would therefore simply extend the old-fashioned "symptomatic" therapy that is based on agents, such as aspirin. This criticism fails to take into account that:
1. In acute viral infections, symptoms lag behind the maximum phase of viral replication; 2. With rare exceptions, antiviral drugs that match the specificity and, in particular, the low host toxicity of antibiotics used to combat bacteria are still not available; and 3. Such a therapy would have a sound scientific basis, because it rests on understanding of the mechanisms causing disease symptoms and pathology.
Finally, one could also argue that, irrespective how old-fashioned a therapy based on a simple drug such as aspirin may be, it has shown beneficial effects in millions of humans suffering from the common cold. Surely, such an approach would not make unneccessary a further search for better antivirals, particularly with severe infections, such as hepatitis or encephalitis. 
